The Efficacy and Safety of GLP-1 RAs in the Modification of Cardiovascular Morbidity in Patients with Obesity Without Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials Involving 32,884 Patients. - Tanashat M; Al-Ajlouni YA; Abuelazm M; Altobaishat O; Manasrah A; Turkmani M; Khan U; Abouzid M (American journal of cardiovascular drugs : drugs, devices, and other interventions, 2025)